We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) (DATiC)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01637558
First Posted: July 11, 2012
Last Update Posted: October 27, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Liverpool School of Tropical Medicine
Uppsala University
University of North Carolina
Information provided by (Responsible Party):
Helen Margaret McIlleron, University of Cape Town
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 31, 2017
  Primary Completion Date: July 31, 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):